Comment on

• Izokibep for the treatment of moderate-to-severe plaque psoriasis: a phase II, randomized, placebo-controlled, double-blind, dose-finding multicentre study including long-term treatment.

  Gerdes S, Staubach P, Dirschka T, Wetzel D, Weirich O, Niesmann J, da Mota R, Rothhaar A, Ardabili M, Vlasitz G, Feldwisch J, Osterling Koskinen L, Ohlman S, Peloso PM, Brun NC, Frejd FY. Gerdes S, et al. Br J Dermatol. 2023 Sep 15;189(4):381-391. doi: 10.1093/bjd/ljad186. Br J Dermatol. 2023. PMID: 37697683 Clinical Trial.